Autoantibodies with Different Level of Specificity and Functionality in the Pathogenesis and Diagnostics of Autoimmune Thyroid Disorders

Cover Page

Abstract



About the authors

References

  1. Lacroix-Desmazes S., Wootla B., Delignat S. et al. Pathophysiology of catalytic antibodies // Immunol. Lett. 2006. V. 28. N 103 (1). P. 3-7.
  2. Harel M., Shoenfeld Y. Predicting and preventing autoimmunity, myth or reality? // Ann. N. Y. Acad. Sci. 2006. V. 1069. P. 322-345.
  3. Sinclair D. Clinical and laboratory aspects of thyroid autoantibodies // Ann. Clin. Biochem. 2006. V. 43 (Pt. 3). P. 173-183.
  4. Routsias J.G., Vlachoyiannopoulos P.G., Tzioufas A.G. Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response // Crit. Rev. Clin. Lab. Sci. 2006. V. 43(3). P. 203-248.
  5. Lee S.J., Kavanaugh A. Autoimmunity, vasculitis and autoantibodies // J. Allergy Clin. Immunol. 2006. V. 117 (2). P. 445-450.
  6. Caforio A.L., Mahon N.G., McKenna W.J. Clinical implications of anti-cardiac immunity in dilated cardiomyopathy // Ernst. Schering Res. Found Workshop. 2006. V. 55. P. 169-193.
  7. Bulow Pedersen I., Laurberg P., Knudsen N. et al. A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure // Clin. Endocrinol. 2005. V. 62 (6). P. 713-720.
  8. Concha L.B., Chang C.C., Szema A.M. et al. IgE antithyroid antibodies in patients with Hashimoto’s disease and chronic urticaria // Allergy Asthma Proc. 2004. V. 25 (5). P. 293-296.
  9. Ng H.P., Banga J.P., Kung A.W. Development of a murine model of autoimmune thyroiditis induced with homologous mouse thyroid peroxidase // Endocrinol. 2004. V. 145 (2). P. 809-816.
  10. Chiovato L., Latrofa F., Braverman L.E. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens // Ann. Intern. Med. 2003. V. 2. N 139. P. 346-351.
  11. Jasani B., Ternynck T., Lazarus J.H. et al. Natural antibody status in patients with Hashimoto’s thyroiditis // J. Clin. Lab. Immunol. 1999. V. 51 (1). P. 9-12.
  12. Sherer Y., Shoenfeld Y. Idiotypic network dysregulation: a common etiopathogenesis of diverse autoimmune diseases // Appl. Biochem Biotechnol. 2000. V. 83. (1-3). P. 155-162.
  13. Невинский Г.А., Канышкова Т.Г. и др. Каталитически активные антитела и их возможная биологическая функция // Вестник РАМН. 2001. № 2. С. 38-45.
  14. Paul S., Li L., Kalaga R., O’Dell J. et al. Characterization of thyroglobulin-directed and polyreactive catalytic antibodies in autoimmune disease // J. Immunol. 1997. V. 1. N 159. P. 1530-1536.
  15. Li L., Kaveri S., Tyutyulkova S. et al. Catalytic activity of anti-thyroglobulin antibodies // Ann. N. Y. Acad. Sci. 1995. V. 29. N 764. P. 570-572.
  16. Franceschi F., Satta M.A., Mentella M.C. et al. Helicobacter pylori infection in patients with Hashimoto’s thyroiditis // Helicobacter. 2004. V. 9 (4). P. 369.
  17. Carayanniotis G., Kong Y.C. Pathogenic thyroglobulin peptides as model antigens: insights on the induction and maintenance of autoimmune thyroiditis // Int. Rev. Immunol. 2000. V. 19 (6). V. 557-572.
  18. Березин В.А. и др. Тиреоглобулин // Эндокринология. 1993. Т. 39, № 4. С. 54-59.
  19. Venkatesh S.G., Deshpande V. A comparative review of the structure and biosynthesis of thyroglobulin // Comp. Biochem. Physiol. Pharmacol. Toxicol Endocrinol. 1999. V. 122 (1). P. 13-20.
  20. Marino M., Pinchera A., McCluskey R.T., Chiovato L. Megalin in thyroid physiology and pathology // Thyroid. 2001. V. 11 (1). P. 47-56.
  21. Okosieme O.E., Parkes A.B., Premawardhana L.D. et al. Thyroglobulin: current aspects of its role in autoimmune thyroid disease and thyroid cancer // Minerva Med. 2003. V. 94 (5). P. 319-330.
  22. Okosieme O.E., Premawardhana L.D., Jayasinghe A. et al. Thyroglobulin autoantibodies in iodized subjects: relationship between epitope specificities and longitudinal antibody activity // Thyroid. 2005. V. 15 (9). P. 1067-1072.
  23. McLachlan S.M., Rapoport B. Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? // Thyroid. 2004. V. 14 (7). P. 510-520.
  24. Barsouk A., Peele K.A., Kiljanski J. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction // J. Endocrinol. Invest. 1996. V. 19 (6). P. 334-341.
  25. Ludgate M.E., Vassart G. The thyrotropin receptor as a model to illustrate receptor and receptor antibody diseases // Baillieres Clin. Endocrinol. Metab. 1995. V. 9 (1). P. 95-113.
  26. Farid N.R., Szkudlinski M.W. Minireview: structural and functional evolution of the thyrotropin receptor // Endocrinology. 2004. V. 145 (9). P. 4048-4057.
  27. Wang H.C., Klein J.R. Immune function of thyroid stimulating hormone and receptor // Crit. Rev. Immunol. 2001. V. 21 (4). P. 323-337.
  28. Quaratino S., Ruf J., Osman M. et al. Human autoantibodies modulate the T cell epitope repertoire but fail to unmask a pathogenic cryptic epitope // J. Immunol. 2005. V. 1. N 174. P. 557-563.
  29. Carayanniotis G., Kong Y.C. Pathogenic thyroglobulin peptides as model antigens: insights on the induction and maintenance of autoimmune thyroiditis // Int. Rev. Immunol. 2000. V. 19 (6). P. 557-572.
  30. Кандрор и др. // БЭБМ. 2004. Т. 138, № 1. С. 37-39.
  31. Watanabe M., Yamamoto N., Maruoka H. Independent involvement of CD8+CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto’s disease // Thyroid. 2002. V. 12 (9). P. 801-808.
  32. Weetman A.P. Cellular immune responses in autoimmune thyroid disease // Clin Endocrinol. 2004. V. 61 (4). 405-413.
  33. Wan Q., McCormick D.J., David C.S., Kong Y.C. Thyroglobulin peptides of specific primary hormonogenic sites can generate cytotoxic T cells and serve as target autoantigens in experimental autoimmune thyroiditis // Clin. Immunol. Immunopathol. 1998. V. 86 (1). P. 110-114.
  34. Сучков С.В., Алекберова З.С., Палеев Ф.Н. и др. Достижения и перспективы клинической абзимологии // Вестник РАМН. 2005. № 9. С. 38-43.
  35. Сучков С.В., Габибов А.Г.. Введение в медицинскую абзимологию: состояние проблемы и перспективы // Вестник РАМН. 2005. № 10. С. 44-43.
  36. Gabibov A. G., Ponomarenko N.A., Tretyak E.B. et al. Catalytic autoantibodies in clinical autoimmunity and modern medicine // Autoimmunity Reviews. 2006. V. 5. P. 324-330.
  37. Bulow Pedersen I., Laurberg P., Knudsen N. et al. A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure // Clin. Endocrinol. 2005. V. 62 (6). P. 713-720.
  38. Rose N.R., Burek C.L. Autoantibodies to thyroglobulin in health and disease // Appl. Biochem Biotechnol. 2000. V. 83 (1-3). P. 245-251.
  39. Rodien P., Madec A.M., Ruf J. et al. Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies // J. Clin. Endocrinol. Metab. 1996. V. 81 (7). P. 2595-2600.
  40. Estienne V., Duthoit C., Costanzo V.D. Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parameters // Eur. J. Endocrinol. 1999. V. 141 (6). P. 563-569.
  41. Nakamura S., Sugimoto M., Kosaka J. Silent thyroiditis with thyroid-stimulation-blocking antibodies (TSBAb) // Jpn. J. Med. 1990. V. 29 (6). P. 623-627.
  42. Morita T., Tamai H., Oshima A. et al. The occurrence of thyrotropin binding-inhibiting immunoglobulins and thyroid-stimulating antibodies in patients with silent thyroiditis // J. Clin. Endocrinol. Metab. 1990. V. 71 (4). P. 1051-1055.
  43. Trbojevic B., Djurica S. Diagnosis of autoimmune thyroid disease // Srp. Arh. Celok. Lek. 2005. V. 133 (1). P. 25-33.
  44. Mann K., Janssen O.E. Subclinical hypothyroidism - what level of TSH is an indication for substitution? // MMW Fortschr Med. 2006. V. 2. (148). N 9. P. 26-29.
  45. Lazarus J.H. Thyroid disease in pregnancy and childhood // Minerva Endocrinol. 2005. V. 30 (2). P. 71-87.
  46. Akamizu T., Kohn L.D., Hiratani H. Hashimoto’s thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies // J. Clin. Endocrinol. Metab. 2000. V. 85 (6).P. 2116-2121.
  47. van Trotsenburg P., Vulsma T., Bloot A.M. et al. Antibodies to “second colloid antigen”. A study on the prevalence in sporadic forms of congenital hypothyroidism // Acta Endocrinol. (Copenh). 1989. V. 121. (5). P. 659-665.
  48. Endo T. Autoantibodies against thyroid hormone // Nippon Rinsho. 2006. V. 28 (1). P. 513-515.
  49. Weetman A.P. Non-thyroid autoantibodies in autoimmune thyroid disease // Best. Pract. Res. Clin. Endocrinol. Metab. 2005. V. 19 (1). P. 17-32.
  50. Chiovato L., Latrofa F., Braverman L.E. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens // Ann. Intern. Med. 2003. V. 2 (139). P. 346-351.
  51. Кеда Ю.М. и др. // Вестник РАМН. 1994. № 12. С. 33-39.
  52. Bresson D., Rebuffat S.A., Peraldi-Roux S. Localization of the immunodominant region on human thyroid peroxidase in autoimmune thyroid diseases: an update // J. Autoimmune Dis. 2005. V. 15. N 2 (1). P. 2.
  53. Rebuffat S.A., Bresson D., Nguyen B., Peraldi-Roux S. The key residues in the immunodominant region 353-363 of human thyroid peroxidase were identified // Int. Immunol. 2006. V. 18 (7). Р. 1091-1009.
  54. Sinclair D. Clinical and laboratory aspects of thyroid autoantibodies // Ann. Clin. Biochem. 2006. V. 43. P. 173-183.
  55. Rose N.R., Burek C.L. Autoantibodies to thyroglobulin in health and disease // Appl. Biochem. Biotechnol. 2000. V. 83 (1-3). P. 245-251.
  56. Bresson D., Rebuffat S.A., Peraldi-Roux S. Localization of the immunodominant region on human thyroid peroxidase in autoimmune thyroid diseases: an update // J. Autoimmune Dis. 2005. V. 15 (2). N 1. P. 2.
  57. Rapoport B., McLachlan S.M. Thyroid autoimmunity // J. Clin. Invest. 2001. V. 108 (9). P. 1253-1259.
  58. Estienne V., Duthoit C., Costanzo V.D. Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parameters // Eur. J. Endocrinol. 1999. V. 141 (6). P. 563-569.
  59. Takasu N., Yamashiro K., Ochi Y. et al. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves’ patients with hyperthyroidism // Horm. Metab. Res. 2001. V. 33 (4). P. 232-237.
  60. Maruyama M., Sanders J., Oda Y. et al. Reactivity of thyrotropin receptor autoantibodies with the thyrotropin receptor on western blots // Thyroid. 2001. V. 11 (3). P. 211-219.
  61. Takasu N., Yamashiro K., Ochi Y. et al. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves’ patients with hyperthyroidism // Horm. Metab. Res. 2001. V. 33 (4). P. 232-237.
  62. Prummel M.F., Wiersinga W.M. Thyroid peroxidase autoantibodies in euthyroid subjects // Best. Pract. Res. Clin. Endocrinol. Metab. 2005. V. 19 (1). P. 1-15.
  63. Spencer C.A. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies // J. Clin. Endocrinol. Metab. 2004. V. 89 (8). P. 3702-3704.
  64. Morgenthaler N.G., Froehlich J., Rendl J. et al. Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin // Clin. Chem. 2002. V. 48 (7). P. 1077-1083.

Statistics

Views

Abstract - 819

PDF (Russian) - 361

Cited-By


PlumX

Dimensions


Copyright (c) 2007 ., ., ., ., ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies